Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Sulzer

Showing results (141-150 of 212) with videos related to

Pageof 22
Sort By:
NPJ Parkinson'S Disease|June 15, 2018
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's diseaseFabio A Zucca, Renzo Vanna, Francesca A Cupaioli, et al.
NPJ Parkinson'S Disease|April 13, 2018
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's diseaseDavid Sulzer, Clifford Cassidy, Guillermo Horga, et al.
Neuron|May 1, 2012
Regulation of presynaptic neurotransmission by macroautophagyDaniela Hernandez, Ciara A Torres, Wanda Setlik, et al.
Science Advances|January 28, 2026
α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene inductionSe Joon Choi, Anika Frank, Manu Ben-Johny, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 17, 2006
Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosisKristin E Larsen, Yvonne Schmitz, Matthew D Troyer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 28, 2014
M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's locationDaniel J Foster, Patrick R Gentry, Jose E Lizardi-Ortiz, et al.
Eneuro|November 28, 2017
α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian NeurotoxinOri J Lieberman, Se Joon Choi, Ellen Kanter, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Altered striatal dopamine regulation in <i>ADGRL3</i> knockout miceNicole A Perry-Hauser, Arturo Torres-Herraez, Siham Boumhaouad, et al.
Neuron|April 11, 2008
Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministrationNigel S Bamford, Hui Zhang, John A Joyce, et al.
Journal of Visualized Experiments : Jove|September 2, 2009
Dopamine release at individual presynaptic terminals visualized with FFNsHui Zhang, Niko G Gubernator, Minerva Yue, et al.
Pageof 22

Showing results (141-150 of 212) with videos related to

Sort By:
Pageof 22
NPJ Parkinson'S Disease|June 15, 2018
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's diseaseFabio A Zucca, Renzo Vanna, Francesca A Cupaioli, et al.
NPJ Parkinson'S Disease|April 13, 2018
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's diseaseDavid Sulzer, Clifford Cassidy, Guillermo Horga, et al.
Neuron|May 1, 2012
Regulation of presynaptic neurotransmission by macroautophagyDaniela Hernandez, Ciara A Torres, Wanda Setlik, et al.
Science Advances|January 28, 2026
α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene inductionSe Joon Choi, Anika Frank, Manu Ben-Johny, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 17, 2006
Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosisKristin E Larsen, Yvonne Schmitz, Matthew D Troyer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 28, 2014
M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's locationDaniel J Foster, Patrick R Gentry, Jose E Lizardi-Ortiz, et al.
Eneuro|November 28, 2017
α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian NeurotoxinOri J Lieberman, Se Joon Choi, Ellen Kanter, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Altered striatal dopamine regulation in <i>ADGRL3</i> knockout miceNicole A Perry-Hauser, Arturo Torres-Herraez, Siham Boumhaouad, et al.
Neuron|April 11, 2008
Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministrationNigel S Bamford, Hui Zhang, John A Joyce, et al.
Journal of Visualized Experiments : Jove|September 2, 2009
Dopamine release at individual presynaptic terminals visualized with FFNsHui Zhang, Niko G Gubernator, Minerva Yue, et al.
Pageof 22